$XXII
22nd Century Group, Inc. Stock $xxii

$xxii Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-Q Financial Statement

#000114420415046007 Filed on August 04, 2015

Income Statement

Concept	2015 Q2	2014 Q2
Revenue	$2.307M	$16.11K
YoY Change	14216.45%
Cost Of Revenue	$2.600M	$13.18K
YoY Change	19636.23%
Gross Profit	-$293.5K	$2.938K
YoY Change	-10089.55%
Gross Profit Margin	-12.72%	18.23%
Selling, General & Admin	$1.588M	$1.379M
YoY Change	15.16%	-1.55%
% of Gross Profit		46931.25%
Research & Development	$283.6K	$263.3K
YoY Change	7.7%	59.51%
% of Gross Profit		8963.07%
Depreciation & Amortization	$78.63K	$74.68K
YoY Change	5.29%	24.47%
% of Gross Profit		2541.83%
Operating Expenses	$2.060M	$2.041M
YoY Change	0.91%	30.37%
Operating Profit	-$2.347M	-$2.038M
YoY Change	15.14%	25.61%
Interest Expense	$13.75K	$1.769K
YoY Change	677.44%	-99.85%
% of Operating Profit
Other Income/Expense, Net	$1.065M	$72.35K
YoY Change	1371.44%	-93.85%
Pretax Income	-$1.289M	-$1.970M
YoY Change	-34.58%	337.78%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.289M	-$1.966M
YoY Change	-34.44%	340.81%
Net Earnings / Revenue	-55.86%	-12199.42%
Basic Earnings Per Share
Diluted Earnings Per Share	-$19.36K	-$33.53K
COMMON SHARES
Basic Shares Outstanding	66.62M shares	58.75M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q2	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.200M	$4.170M
YoY Change	96.64%	826.67%
Cash & Equivalents	$8.197M	$4.173M
Short-Term Investments
Other Short-Term Assets	$460.0K	$250.0K
YoY Change	84.0%	733.33%
Inventory	$2.382M	$1.733M
Prepaid Expenses		$251.1K
Receivables	$449.5K	$16.11K
Other Receivables	$600.0K	$0.00
Total Short-Term Assets	$12.13M	$6.218M
YoY Change	95.09%	247.63%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.716M	$2.950M
YoY Change	-7.94%	10509.98%
Goodwill
YoY Change
Intangibles	$7.206M
YoY Change
Long-Term Investments	$1.230M	$250.0K
YoY Change	392.0%
Other Assets
YoY Change
Total Long-Term Assets	$11.15M	$2.071M
YoY Change	438.35%	50.84%
TOTAL ASSETS
Total Short-Term Assets	$12.13M	$6.218M
Total Long-Term Assets	$11.15M	$2.071M
Total Assets	$23.28M	$11.24M
YoY Change	107.1%	255.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$984.7K	$730.0K
YoY Change	34.89%	72.76%
Accrued Expenses	$1.149M	$660.0K
YoY Change	74.04%	100.09%
Deferred Revenue
YoY Change
Short-Term Debt	$170.0K	$170.0K
YoY Change	0.0%	-54.05%
Long-Term Debt Due	$330.0K
YoY Change
Total Short-Term Liabilities	$2.927M	$1.562M
YoY Change	87.46%	-31.48%
LONG-TERM LIABILITIES
Long-Term Debt	$610.0K	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$3.180M	$550.0K
YoY Change	478.18%	-93.06%
Total Long-Term Liabilities	$3.790M	$550.0K
YoY Change	589.09%	-93.21%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.927M	$1.562M
Total Long-Term Liabilities	$3.790M	$550.0K
Total Liabilities	$6.710M	$2.111M
YoY Change	217.91%	-79.65%
SHAREHOLDERS EQUITY
Retained Earnings	-$60.93M	-$47.21M
YoY Change	29.06%	182.1%
Common Stock	$708.00	$593.00
YoY Change	19.39%	33.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$16.57M	$9.130M
YoY Change
Total Liabilities & Shareholders Equity	$23.28M	$11.24M
YoY Change	107.09%	255.55%

Cashflow Statement

Concept	2015 Q2	2014 Q2
OPERATING ACTIVITIES
Net Income	-$1.289M	-$1.966M
YoY Change	-34.44%	340.81%
Depreciation, Depletion And Amortization	$78.63K	$74.68K
YoY Change	5.29%	24.47%
Cash From Operating Activities	-$1.080M	-$1.110M
YoY Change	-2.7%	200.0%
INVESTING ACTIVITIES
Capital Expenditures	-$140.0K	-$50.00K
YoY Change	180.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$330.0K
YoY Change	-100.0%
Cash From Investing Activities	-$140.0K	-$390.0K
YoY Change	-64.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	5.570M	300.0K
YoY Change	1756.67%	-45.45%
NET CHANGE
Cash From Operating Activities	-1.080M	-1.110M
Cash From Investing Activities	-140.0K	-390.0K
Cash From Financing Activities	5.570M	300.0K
Net Change In Cash	4.350M	-1.200M
YoY Change	-462.5%	-766.67%
FREE CASH FLOW
Cash From Operating Activities	-$1.080M	-$1.110M
Capital Expenditures	-$140.0K	-$50.00K
Free Cash Flow	-$940.0K	-$1.060M
YoY Change	-11.32%	186.49%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q2	us-gaap	Inventory Net InventoryNet	2381923	USD
CY2015Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	0	USD
CY2014Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1978785	USD
CY2015Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	455625	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	214469	USD
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2715807	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2850615	USD
CY2015Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7205927	USD
CY2015Q2	us-gaap	Advances To Affiliate AdvancesToAffiliate	1226520	USD
CY2014Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate	1318335	USD
CY2015Q2	xxii	Assests Noncurrent Excluding Property Plant And Equipment Net AssestsNoncurrentExcludingPropertyPlantAndEquipmentNet	8432447	USD
CY2014Q4	xxii	Assests Noncurrent Excluding Property Plant And Equipment Net AssestsNoncurrentExcludingPropertyPlantAndEquipmentNet	8396094	USD
CY2015Q2	us-gaap	Assets Assets	23278071	USD
CY2014Q4	us-gaap	Assets Assets	21953515	USD
CY2015Q2	us-gaap	Interest Expense InterestExpense	13753	USD
CY2015Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16567623	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15219737	USD
CY2014Q2	us-gaap	Sales Revenue Goods Gross SalesRevenueGoodsGross	16114	USD
CY2015Q2	us-gaap	Sales Revenue Goods Gross SalesRevenueGoodsGross	2306953	USD
CY2015Q2	us-gaap	Gross Profit GrossProfit	-293493	USD
CY2014Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	274582	USD
CY2015Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	0	USD
CY2014Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	124344	USD
CY2015Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	163827	USD
CY2014Q2	us-gaap	Interest Expense InterestExpense	1769	USD
	us-gaap	Sales Revenue Goods Gross SalesRevenueGoodsGross	2923091	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	3233026	USD
	us-gaap	Gross Profit GrossProfit	-309935	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	491080	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	0	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	324718	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6466199	USD
	xxii	Gain Loss From Warrant Liability GainLossFromWarrantLiability	171833	USD
	xxii	Warrant Exchange Inducement Expense WarrantExchangeInducementExpense	144548	USD
CY2014Q2	us-gaap	Cash Cash	4172795	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	884412	USD
CY2015Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1148668	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1081545	USD
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2927172	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2673407	USD
CY2015Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	984664	USD
CY2014Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	13176	USD
CY2014Q2	us-gaap	Gross Profit GrossProfit	2938	USD
CY2014Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	263335	USD
CY2015Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2600446	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	10706806	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2038163	USD
CY2014Q2	xxii	Gain Loss From Warrant Liability GainLossFromWarrantLiability	74117	USD
CY2014Q2	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	0	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-1965815	USD
CY2014Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.03
CY2014Q4	xxii	Accrued Severance Liabilities Current AccruedSeveranceLiabilitiesCurrent	212012	USD
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	308105	USD
CY2015Q2	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	174925	USD
CY2014Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	174925	USD
CY2015Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	2871013	USD
CY2014Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	3042846	USD
CY2015Q2	us-gaap	Liabilities Liabilities	6710448	USD
CY2014Q4	us-gaap	Liabilities Liabilities	6733778	USD
CY2015Q2	us-gaap	Common Stock Value CommonStockValue	708	USD
CY2015Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	77497451	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	70744190	USD
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-60930536	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-55525094	USD
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23278071	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21953515	USD
CY2015Q2	us-gaap	Notes Payable Current NotesPayableCurrent	332497	USD
CY2014Q4	us-gaap	Notes Payable Current NotesPayableCurrent	320513	USD
CY2015Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	605217	USD
CY2014Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	605217	USD
CY2015Q2	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	307046	USD
CY2014Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	412308	USD
CY2015Q2	xxii	Accrued Severance Liabilities Current AccruedSeveranceLiabilitiesCurrent	286418	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	2064796	USD
CY2015Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	449461	USD
CY2015Q2	us-gaap	Assets Current AssetsCurrent	12129817	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2346736	USD
CY2015Q2	xxii	Gain Loss From Warrant Liability GainLossFromWarrantLiability	112620	USD
CY2015Q2	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-40834	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-1288703	USD
CY2015Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58749240	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66616739	shares
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	449461	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	85621	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-91815	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65408908	shares
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4934462	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	406004	USD
	us-gaap	Interest Expense InterestExpense	19261	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	886745	USD
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	325000	USD
	xxii	Warrant Exchange Inducement Expense WarrantExchangeInducementExpense	0	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	34500	USD
	us-gaap	Profit Loss ProfitLoss	-7280943	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	195613	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	324718	USD
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	0	USD
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	49011	USD
	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	0	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	85621	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
	xxii	Gain Loss From Warrant Liability GainLossFromWarrantLiability	-3993153	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	994049	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	288841	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	251095	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	433339	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	108396	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	392123	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-179014	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2232530	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3604029	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	89352	USD
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	130184	USD
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	4631	USD
	us-gaap	Proceeds From Sale Of Machinery And Equipment ProceedsFromSaleOfMachineryAndEquipment	631484	USD
	us-gaap	Proceeds From Sale Of Machinery And Equipment ProceedsFromSaleOfMachineryAndEquipment	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	69054	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-143502	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	466201	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	34500	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	25200	USD
	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	0	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	7471	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	505672	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	5541583	USD
CY2013Q4	us-gaap	Cash Cash	5830599	USD
CY2014Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	3031375	USD
CY2014Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	55355	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	236115	USD
	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P8Y7M28D
	xxii	Patent And Trademark Additions Included In Accounts Payable PatentAndTrademarkAdditionsIncludedInAccountsPayable	213800	USD
	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	18000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	25852	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	325000	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0	USD
	us-gaap	Interest Paid Net InterestPaidNet	3537	USD
	us-gaap	Interest Paid Net InterestPaidNet	7296	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	16114	USD
	xxii	Reclassification Of Machinery And Equipment Purchases To Inventory ReclassificationOfMachineryAndEquipmentPurchasesToInventory	0	USD
	xxii	Reclassification Of Machinery And Equipment Purchases To Inventory ReclassificationOfMachineryAndEquipmentPurchasesToInventory	37856	USD
	xxii	Reclassification Of Derivative Liability To Equity Due To Warrant Amendments ReclassificationOfDerivativeLiabilityToEquityDueToWarrantAmendments	0	USD
	xxii	Reclassification Of Derivative Liability To Equity Due To Warrant Amendments ReclassificationOfDerivativeLiabilityToEquityDueToWarrantAmendments	7367915	USD
	xxii	Patent And Trademark Additions Included In Accounts Payable PatentAndTrademarkAdditionsIncludedInAccountsPayable	205586	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1794052	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1657804	USD
	xxii	Increase Decrease In Accrued Severance IncreaseDecreaseInAccruedSeverance	-30857	USD
	xxii	Increase Decrease In Accrued Severance IncreaseDecreaseInAccruedSeverance	0	USD
	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	34500	USD
	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	0	USD
	xxii	Inventory Reserve Adjustments InventoryReserveAdjustments	-60000	USD
	xxii	Inventory Reserve Adjustments InventoryReserveAdjustments	0	USD
CY2015Q2	xxii	Inventory Tobacco Leaf Gross InventoryTobaccoLeafGross	1554258	USD
CY2014Q4	xxii	Inventory Tobacco Leaf Gross InventoryTobaccoLeafGross	1537521	USD
CY2015Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	110623	USD
CY2014Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	50623	USD
CY2015Q2	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	402605	USD
CY2014Q4	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	154568	USD
CY2015Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	535683	USD
CY2014Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	423330	USD
CY2015Q2	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.2	pure
	xxii	Working Capital WorkingCapital	9202645	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8196739	USD
CY2015Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	3031375	USD
CY2015Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	77987	USD
CY2014Q2	us-gaap	Equity Method Investments EquityMethodInvestments	250000	USD
	xxii	Percentage Of Net Loss PercentageOfNetLoss	0.25	pure
CY2014Q2	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.1	pure
	us-gaap	Debt Instrument Basis Spread On Variable Rate1 DebtInstrumentBasisSpreadOnVariableRate1	0.0075	pure
CY2015Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0400	pure
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2015-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Registrant Name EntityRegistrantName	22nd Century Group, Inc.
	dei	Entity Central Index Key EntityCentralIndexKey	0001347858
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Trading Symbol TradingSymbol	XXII
CY2015Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	70873164	shares
CY2014Q4	us-gaap	Severance Costs1 SeveranceCosts1	624320	USD
	xxii	Severance Term SeveranceTerm	P36M
CY2014Q4	xxii	Finite Lived Intangible Assets Acquired With Notes Payable FiniteLivedIntangibleAssetsAcquiredWithNotesPayable	925730	USD
CY2014Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	605217	USD
CY2014	xxii	Finite Lived Intangible Assets Acquired With Notes Payable FiniteLivedIntangibleAssetsAcquiredWithNotesPayable	925730	USD
	us-gaap	Debt Instrument Frequency Of Periodic Payment DebtInstrumentFrequencyOfPeriodicPayment	30 days
CY2015Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2015Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	70773164	shares
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	70773164	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	64085042	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	64085042	shares
CY2015Q2	xxii	Property Plant And Equipment Including Assets Held For Sale PropertyPlantAndEquipmentIncludingAssetsHeldForSale	3109362	USD
CY2014Q4	xxii	Property Plant And Equipment Including Assets Held For Sale PropertyPlantAndEquipmentIncludingAssetsHeldForSale	3086730	USD
CY2015Q2	us-gaap	Depreciation Depreciation	78630	USD
	us-gaap	Depreciation Depreciation	157440	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	2053243	USD
CY2014Q2	us-gaap	Operating Expenses OperatingExpenses	2041101	USD
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1058033	USD
CY2014Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	72348	USD
CY2015Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	1000000	USD
CY2014Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
CY2014Q2	us-gaap	Depreciation Depreciation	74679	USD
	us-gaap	Depreciation Depreciation	75535	USD
	us-gaap	Sales Revenue Goods Gross SalesRevenueGoodsGross	463649	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	190872	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	485715	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2349867	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	432767	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	34160	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	195613	USD
	us-gaap	Operating Expenses OperatingExpenses	6156264	USD
	us-gaap	Operating Expenses OperatingExpenses	3498122	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3225345	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	1000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
	us-gaap	Interest Expense InterestExpense	3518	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1060757	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4055598	USD
	us-gaap	Net Income Loss NetIncomeLoss	-7280943	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.13
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58075029	shares
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	250000	USD
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1952000	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	105000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5576083	USD
CY2015Q2	xxii	Inventorytobacco Leaf Net InventorytobaccoLeafNet	2492546	USD
CY2014Q4	xxii	Inventorytobacco Leaf Net InventorytobaccoLeafNet	2115419	USD
CY2015Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	109702	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	216289	USD
CY2014Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	49665	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	120078	USD
CY2015Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	600000	USD
CY2014Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	0	USD
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	600000	USD
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	0	USD
	us-gaap	Accretion Expense AccretionExpense	11984	USD
CY2015Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.25
	us-gaap	Gross Profit GrossProfit	272777	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	5576083	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	342894	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	2500	USD
CY2015Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	16674778	shares
CY2014Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0400	pure
CY2014	us-gaap	Debt Instrument Basis Spread On Variable Rate1 DebtInstrumentBasisSpreadOnVariableRate1	0.0075	pure
CY2012Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	4173140	USD
CY2013Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	6022319	USD
CY2013Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	711675	USD
CY2013Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1622069	USD
	xxii	Reclassification Of Warrant Liability To Equity Upon Exercise Of Warrants ReclassificationOfWarrantLiabilityToEquityUponExerciseOfWarrants	204513	USD
	xxii	Reclassification Of Warrant Liability To Equity Upon Exercise Of Warrants ReclassificationOfWarrantLiabilityToEquityUponExerciseOfWarrants	6542904	USD
CY2013	xxii	Reclassification Of Warrant Liability To Equity Upon Exercise Of Warrants ReclassificationOfWarrantLiabilityToEquityUponExerciseOfWarrants	7712170	USD
CY2013	xxii	Inducement Costs From Warrant Amendments InducementCostsFromWarrantAmendments	3274313	USD
CY2013	xxii	Reclassification Of Warrant Liability To Equity Resulting From Warrant Exchange Program ReclassificationOfWarrantLiabilityToEquityResultingFromWarrantExchangeProgram	19639465	USD
CY2013	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	19271977	USD
CY2013Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	3779522	USD
CY2014Q1	xxii	Inducement Costs From Warrant Amendments InducementCostsFromWarrantAmendments	144548	USD
CY2014	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	3676691	USD
	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	171833	USD
CY2012Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	12972664	shares
CY2013Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	10653469	shares
CY2013Q4	xxii	Class Of Warrant Or Right Issued ClassOfWarrantOrRightIssued	11570274	shares
CY2013	xxii	Class Of Warrants Or Rights Issued Under Warrant Exchange Program ClassOfWarrantsOrRightsIssuedUnderWarrantExchangeProgram	138666	shares
CY2013	xxii	Common Stock Warrants Issued Additional Number CommonStockWarrantsIssuedAdditionalNumber	1665400	shares
CY2013	xxii	Number Of Warrants Exercised NumberOfWarrantsExercised	9831414	shares
CY2013	xxii	Number Of Warrants Exercised Under Warrant Exchange Program NumberOfWarrantsExercisedUnderWarrantExchangeProgram	5862121	shares
CY2014	xxii	Warrants Issued In Conjunction With Consulting Agreement WarrantsIssuedInConjunctionWithConsultingAgreement	4250000	shares
CY2014	xxii	Number Of Warrants Exercised NumberOfWarrantsExercised	1247443	shares
CY2014	xxii	Common Stock Warrants Issued Additional Number CommonStockWarrantsIssuedAdditionalNumber	18383	shares
	xxii	Common Stock Warrants Issued Additional Number CommonStockWarrantsIssuedAdditionalNumber	369	shares
	xxii	Warrants With Provision Of Anti Dilution WarrantsWithProvisionOfAntiDilution	130178	shares
	xxii	Warrants Without Provision Of Anti Dilution WarrantsWithoutProvisionOfAntiDilution	16544600	shares
CY2015Q2	xxii	Warrants Outstanding WarrantsOutstanding	16674778	shares
	xxii	Warrants Issued In Conjunction With Registered Direct Offering WarrantsIssuedInConjunctionWithRegisteredDirectOffering	3000000	shares
CY2013Q4	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue	3921381	USD
CY2014	xxii	Warrants Without Provision Of Anti Dilution WarrantsWithoutProvisionOfAntiDilution	13544600	shares
CY2014	xxii	Warrants With Provision Of Anti Dilution WarrantsWithProvisionOfAntiDilution	129809	shares
CY2015Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	112620	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	171833	USD
CY2014Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	74117	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	3993153	USD
	xxii	Warrants Expiration Period WarrantsExpirationPeriod	P66M
CY2015Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2014Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2015Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	66616739	shares
CY2014Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	58749240	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	65408908	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	58075029	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10600784	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	19436420	shares
	xxii	Common Stock And Warrants Issued To Purchase Common Stock CommonStockAndWarrantsIssuedToPurchaseCommonStock	3000000	shares
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	65000	USD
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	146000	USD
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	156000	USD
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	169000	USD
CY2015Q2	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	24506	USD
CY2014Q2	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	0	USD
CY2015Q2	xxii	Lease Payments LeasePayments	30750	USD
	xxii	Lease Payments LeasePayments	61500	USD
CY2014Q2	xxii	Lease Payments LeasePayments	24000	USD
	xxii	Lease Payments LeasePayments	45093	USD
CY2015Q1	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	225000	USD
CY2015Q2	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	675000	USD
CY2015Q1	us-gaap	Litigation Reserve LitigationReserve	46069	USD
CY2015Q2	us-gaap	Proceeds From Legal Settlements ProceedsFromLegalSettlements	400000	USD
CY2015Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2015Q2	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2015Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.00
	xxii	Common Stock And Warrants Issued To Purchase Common Stock CommonStockAndWarrantsIssuedToPurchaseCommonStock	3000000	shares
	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0150	pure
	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0180	pure
	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	0.9	pure
	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	0.9	pure
	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P10Y
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	465000	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	215000	shares
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	20000	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	300000	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	890000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	660000	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2661642	shares
CY2014	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	70000	shares
	xxii	Share Based Compensation Arrangement By Sharebased Payment Award Options Reinstated In Period ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsReinstatedInPeriod	50000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1721642	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	790000	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.69
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.80
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.61
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.08
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.26
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.69
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.74
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.17
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.38
	xxii	Share Based Compensation Arrangements By Share Based Payment Award Options Reinstated In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsReinstatedInPeriodWeightedAverageExercisePrice	0.69
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.10
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y4M24D
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	148800	USD
CY2015Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	135600	USD
CY2015Q2	us-gaap	Share Based Compensation ShareBasedCompensation	331773	USD
CY2014Q2	us-gaap	Share Based Compensation ShareBasedCompensation	637365	USD
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	189196	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	100000	shares
CY2015Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1017000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1721642	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	300000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.59
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.07
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-50000	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	206500	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	103250	USD
CY2014Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	13674409	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 29.7pt; MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 29.7pt; MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><i><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Use of Estimates</i> -</strong> The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 29.7pt; MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif"> <i><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><strong> Reclassifications</strong> -</i> Certain items in the 2014 financial statements have been reclassified to conform to the 2015 classification.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Substantial Doubt About Going Concern Managements Plans Substantial Doubt Alleviated SubstantialDoubtAboutGoingConcernManagementsPlansSubstantialDoubtAlleviated	The Company believes it will have adequate cash reserves to sustain operations and meet all current obligations as they come due for a period of approximately 12 months.
	us-gaap	Description Of Regulatory Requirements Capital Adequacy Purposes DescriptionOfRegulatoryRequirementsCapitalAdequacyPurposes	The universal shelf registration statement will allow, but not compel, the Company to raise up to approximately $33 million of capital over a three-year period after the effectiveness of the registration statement through a wide array of securities at times and in amounts to be determined by the Company
	us-gaap	Accretion Expense AccretionExpense	0	USD
CY2015Q2	xxii	Fair Value Of Warrants FairValueOfWarrants	2067000	USD
CY2014Q3	xxii	Fair Value Of Warrants FairValueOfWarrants	2067000	USD
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	169000	USD
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	169000	USD
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	141000	USD

Files In Submission

Name	View Source	Status
0001144204-15-046007-index-headers.html	Edgar Link	pending
0001144204-15-046007-index.html	Edgar Link	pending
0001144204-15-046007.txt	Edgar Link	pending
0001144204-15-046007-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v416146_10q.htm	Edgar Link	pending
v416146_ex31-1.htm	Edgar Link	pending
v416146_ex31-2.htm	Edgar Link	pending
v416146_ex32-1.htm	Edgar Link	pending
xxii-20150630.xml	Edgar Link	completed
xxii-20150630.xsd	Edgar Link	pending
xxii-20150630_cal.xml	Edgar Link	unprocessable
xxii-20150630_def.xml	Edgar Link	unprocessable
xxii-20150630_lab.xml	Edgar Link	unprocessable
xxii-20150630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XXII
22nd Century Group, Inc. Stock $xxii

2015 Q2 Form 10-Q Financial Statement

#000114420415046007 Filed on August 04, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XXII 22nd Century Group, Inc. Stock $xxii

2015 Q2 Form 10-Q Financial Statement

#000114420415046007 Filed on August 04, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XXII
22nd Century Group, Inc. Stock $xxii